Podrobno

Dynamics of leukocyte telomere length in patients with Fabry disease
ID Levstek, Tina (Avtor), ID Breznik, Nika (Avtor), ID Vujkovac, Bojan (Avtor), ID Nowak, Albina (Avtor), ID Trebušak Podkrajšek, Katarina (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (731,45 KB)
MD5: A759E4D57021AA05463423E5FC00CA8F
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2227-9059/12/8/1724 Povezava se odpre v novem oknu

Izvleček
Fabry disease (FD) leads to significant morbidity and mortality, which may indicate accelerated ageing. However, it is still unclear whether there is a relationship between telomere length (TL), a marker of biological ageing, and disease outcome. We aimed to examine the relationship between leukocyte TL (LTL) dynamics and the presence of advanced disease stages and/or late complications of FD, including hypertrophic cardiomyopathy, nephropathy and stroke, both cross-sectionally and longitudinally. DNA was extracted from peripheral blood leukocytes and quantitative PCR was utilized to determine relative LTL in 99 Fabry patients. In the longitudinal analysis, we included 50 patients in whom at least three measurements were performed over a period of 5–10 years. The results showed a significant inverse correlation between LTL and age (ρ = −0.20, p = 0.05). No significant differences in LTL were found between females and males (p = 0.79) or between patients receiving disease-specific therapy and those without (p = 0.34). In a cross-sectional analysis, no association was found between the presence (p = 0.15) or number (p = 0.28) of advanced stages of the disease and/or late complications and LTL. Similarly, in a longitudinal analysis, no difference in LTL dynamics was found regarding the presence (p = 0.16) of advanced stage organ involvement and/or late complications or their number. These findings indicate that LTL dynamics in adulthood may not be a reliable indicator of disease outcomes in Fabry patients. Therefore, LTL may more accurately reflect the disease burden in early life, when TL is primarily determined.

Jezik:Angleški jezik
Ključne besede:Fabry disease, telomere length, hyperthropic cardiomyopathy, nephropathy, stroke
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:9 str.
Številčenje:Vol. 12, iss. 8, art. 1724
PID:20.500.12556/RUL-166796 Povezava se odpre v novem oknu
UDK:616-07
ISSN pri članku:2227-9059
DOI:10.3390/biomedicines12081724 Povezava se odpre v novem oknu
COBISS.SI-ID:203575043 Povezava se odpre v novem oknu
Datum objave v RUL:24.01.2025
Število ogledov:221
Število prenosov:95
Metapodatki:XML DC-XML DC-RDF
:
LEVSTEK, Tina, BREZNIK, Nika, VUJKOVAC, Bojan, NOWAK, Albina in TREBUŠAK PODKRAJŠEK, Katarina, 2024, Dynamics of leukocyte telomere length in patients with Fabry disease. Biomedicines [na spletu]. 2024. Vol. 12, no. 8,  1724. [Dostopano 8 april 2025]. DOI 10.3390/biomedicines12081724. Pridobljeno s: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=166796
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Biomedicines
Skrajšan naslov:Biomedicines
Založnik:MDPI AG
ISSN:2227-9059
COBISS.SI-ID:523006745 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:Fabrijeva bolezen, dolžina telomer, hipertrofična kardiomiopatija, nefropatija, kap

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0170
Naslov:Molekulski mehanizmi uravnavanja celičnih procesov v povezavi z nekaterimi boleznimi pri človeku

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J3-50113
Naslov:Prepoznavanje in longitudinalna opredelitev bioloških označevalcev razvoja in napredovanja nefropatije pri Fabryjevi bolezni

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Takeda Pharmaceuticals

Financer:Drugi - Drug financer ali več financerjev
Program financ.:University Foundation of ing. Lenarčič Milan

Podobna dela

Podobna dela v RUL:
  1. Regresija z Gaussovimi procesi
  2. Zasnova dinamičnega dušilnika v interoperabilnem sistemu
  3. Numerična optimizacija vodilnika centrifugalnega puhala
  4. Dinamična izbira metod za profiliranje spletnih uporabnikov
  5. Numerična optimizacija togosti laminiranih kompozitnih struktur
Podobna dela v drugih slovenskih zbirkah:
  1. Improving medical decision making by self organizing intelligent systems
  2. Značilnost okolja Kuberflow
  3. Gradnja priporočilnega sistema na platformi Turi
  4. Sentimentalna analiza tweetov
  5. Izločevanje informacij in indukcija ovojnice

Nazaj